1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1b/2 umbrella study of investigational immune and targeted combination therapies as first-line therapy for patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Plimack, E. R.; Hammers, H. J.; Choueiri, T. K.; Rini, B. I.; Motzer, R. J.; Suttner, L.; Perini, R. F.; Rogerio, J. W.; Albiges, L.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase III trial of docetaxel versus docetaxel and radium-223 (Ra-223) in patients with metastatic castration-resistant prostate cancer (mCRPC): DORA
    Meeting Abstract

    Morris, M. J.; De Wit, R.; Vogelzang, N. J.; Tagawa, S. T.; Higano, C. S.; Hamberg, P.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Long-term trend of quality-adjusted time without symptoms or toxicities (Q-TWiST) of nivolumab+ipilimumab (N+I) versus sunitinib (SUN) for the first-line treatment of advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Motzer, R. J.; Choueiri, T. K.; May, J.; Kwon, Y.; Rusibamayila, N.; Botteman, M.; Hamilton, M.; Ejzykowicz, F.; Cella, D.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • TROP-2 co-expression with androgen receptor splice variants as a new therapeutic target in prostate cancer
    Meeting Abstract

    Stahlfeld, C.; Sperger, J.; Slovin, S. F.; Tagawa, S. T.; Kyriakopoulos, C.; Kohli, M.; Wang, L. G.; Wang, L. W.; Dehm, S.; Lang, J. M.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial
    Meeting Abstract

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H. A.; Quinlan, C.; Teo, M. Y.; Kamradt, J.; Khalil, M. F.; Ostrovnaya, I.; McCoy, A. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Immunity to childhood vaccines following high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) for germ cell tumors (GCT) with comparison to Hodgkin lymphoma (HL)
    Meeting Abstract

    Feldman, D. R.; Lewis, A. R.; Knezevic, A.; Ali, D.; Bromberg, M.; Aronson, J.; Funt, S. A.; McHugh, D. J.; Motzer, R. J.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Institutional experience with nab-sirolimus in patients with malignancies harboring TSC1 or TSC2 mutations
    Meeting Abstract

    Dickson, M. A.; Ravi, V.; Ganjoo, K. N.; Iyer, G.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Reznik, E.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Tassone, D.; Dadoun, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer
    Meeting Abstract

    Jee, J.; Lebow, E. S.; Murciano-Goroff, Y. R.; Jayakumaran, G.; Shen, R.; Brannon, A. R.; Benayed, R.; Namakydoust, A.; Offin, M.; Paik, P. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Effect of pretreatment central adiposity on the cardiometabolic risk of male germ cell tumor survivors after cisplatin-based chemotherapy
    Meeting Abstract

    Wibmer, A. G.; Feldman, D. R.; Chen, C.; Bromberg, M.; Dinh, P. C.; Zheng, J.; Capanu, M.; Travis, L. B.; Vargas, H. A.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save